These data support a role for IFN-I and IL-15 in promoting the differentiation of CD38+ HLA-DR+ T and NK cells and illustrate the potential utility of JAK inhibitors and possibly mTOR inhibitors to control the expansion of these cells in MAS. This evidence concerns the gene IL15 and macrophage activation syndrome.